Citation Impact
Citing Papers
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients
2007 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
Monitoring of viral levels during therapy of hepatitis C
2002
Hepatitis C Virus–Specific CD4+T Cell Response after Liver Transplantation Occurs Early, Is Multispecific, Compartmentalizes to the Liver, and Does Not Correlate with Recurrent Disease
2001 StandoutNobel
NEW AGENTS FOR SEDATION IN THE INTENSIVE CARE UNIT
2001
Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone
2002
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Hepatitis C Virus Infection
2001 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Diagnostic tests for hepatitis C
1999
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Quantification of Serum Hepatitis C Virus RNA with Daily or Standard Interferon Doses Plus Ribavirin in Nonresponder Patients with Chronic Hepatitis C
2000
Treatment of Acute Hepatitis C with Interferon Alfa-2b
2001
Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C
2003
Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications
2002
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Effect of pegylation on pharmaceuticals
2003 Standout
Dynamics of Alanine Aminotransferase During Hepatitis C Virus Treatment
2003
Combination of interferon induction therapy and ribavirin in chronic hepatitis C
2001
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection
2006 StandoutNobel
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Detection of widespread hepatocyte infection in chronic hepatitis C
1998
Innate Immune Tolerance and the Role of Kupffer Cells in Differential Responses to Interferon Therapy Among Patients With HCV Genotype 1 Infection
2012
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Polymer conjugates as anticancer nanomedicines
2006 Standout
Hepatitis C virus–specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C
2000
Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
1999
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Viral Dynamics and Response Differences in Hcv–Infected African American and White Patients Treated With Ifn and Ribavirin
2003
Chronic hepatitis B
2007 Standout
USE AND INTERPRETATION OF HCV DIAGNOSTIC TESTS IN THE CLINICAL SETTING
1997
Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study
2000
A diverse range of gene products are effectors of the type I interferon antiviral response
2011 StandoutNatureNobel
Treatment of chronic hepatitis C with PEGylated interferon and ribavirin
2002
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
2000
Current therapy for chronic hepatitis C
2000
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin
2002
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
2004 StandoutNobel
Standardization of Hepatitis C Virus RNA Quantification
2000
Pathogenesis, diagnosis and management of hepatitis C
2000
Pegylation
2001
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Dynamics of Hepatitis C Viremia following Interferon‐α Administration
1998
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees
2004 StandoutNobel
Genomic response to interferon-α in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics
2006
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
1999 StandoutNobel
The dawning era of polymer therapeutics
2003 Standout
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C
2001
Replication of hepatitis C virus
2007 StandoutNobel
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Monitoring of viral levels during therapy of hepatitis C
2002
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication
2003 StandoutNobel
Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro
2002
CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection
2004 StandoutNobel
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications
2015
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations
1998
Broad Specificity of Virus-Specific CD4+T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection
2002
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells
2006 StandoutNobel
Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs
2002 StandoutNobel
Management of chronic hepatitis C in HIV-infected patients
1999
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
2004 Standout
Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity
2009 StandoutNobel
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Intrahepatic Hepatitis C Virus Replication Correlates with Chronic Hepatitis C Disease Severity In Vivo
2006
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Natalie Lam being referenced
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
1997
Pharmacokinetics of dexmedetomidine (DEX) in patients with hepatic failure (HF)
1999
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
1997